The National Ovarian Cancer Early Detection Program (NOCEDP) is a clinical and research program. The clinical program combines the expertise of gynecologic oncology, genetics, ultrasonography, biochemistry, and molecular biology to offer a comprehensive detection program for women at risk for developing ovarian cancer and for women diagnosed with ovarian cancer. The research program is designed to identify detection tools, prevention methods and therapies, and to improve quality of life for women at increased risk of developing ovarian cancer and for those with the disease. In addition, we help women understand their risk factors for ovarian cancer and identify women at increased risk.

• Have a personal history of breast or colon cancer
• Have one or more first degree relatives (mother, sister, daughter) with ovarian, primary peritoneal or fallopian tube cancer
• Have two or more family members with either breast, ovarian, primary peritoneal, fallopian tube, colon, uterine and/or pancreatic cancer
• Have a personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer. This includes a BRCA 1 and BRCA 2 genetic mutation or Lynch syndrome (HNPCC)
• Have a diagnosis of a reproductive cancer or a highly suspicious adnexal mass

< < Previous Page